Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-11-01 Sale |
2024-11-05 4:23 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $844.61 | $844,610 | 19,105 (Indirect Direct) |
View |
| 2024-10-01 Sale |
2024-10-03 4:02 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $1,049 | $104,878 | 17,582 (Direct) |
View |
| 2024-10-01 Sale |
2024-10-03 4:02 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $1,054 | $1,054,060 | 20,105 (Indirect Direct) |
View |
| 2024-09-03 Sale |
2024-09-05 4:01 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $1,179 | $1,178,730 | 21,105 (Indirect Direct) |
View |
| 2024-09-03 Sale |
2024-09-05 4:01 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $1,179 | $117,868 | 17,682 (Direct) |
View |
| 2024-08-28 Sale |
2024-08-29 4:27 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Finance & CFO |
5,680 | $1,205 | $6,846,262 | 18,742 (Indirect Direct) |
View |
| 2024-08-15 Sale |
2024-08-19 4:02 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
756 | $1,170 | $884,520 | 2,898 (Direct) |
View |
| 2024-08-15 Sale |
2024-08-19 4:01 pm |
REGENERON PHARMACEUTICALS INC. | REGN | POON CHRISTINE A Director |
10,838 | $1,158 | $12,552,285 | 2,172 (Direct) |
View |
| 2024-08-14 Sale |
2024-08-15 4:01 pm |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
6,363 | $1,153 | $7,337,505 | 52,632 (Indirect Direct) |
View |
| 2024-08-08 Sale |
2024-08-12 4:05 pm |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
5,197 | $1,085 | $5,636,346 | 60,553 (Indirect Direct) |
View |
| 2024-08-07 Sale |
2024-08-07 4:40 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Pitofsky Jason VP Controller |
487 | $1,070 | $521,090 | 4,214 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-02 Option Award |
2025-01-06 5:42 pm |
N/A 2035-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | Schenkein David P Director |
2,124 | $0 | 2,406 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:13 pm |
N/A 2035-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | Thompson Craig B. Director |
2,124 | $0 | 2,578 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:12 pm |
N/A 2035-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director |
2,124 | $0 | 3,517 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:11 pm |
N/A 2035-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director |
2,124 | $0 | 3,506 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:08 pm |
N/A 2035-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
2,124 | $0 | 19,706 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:07 pm |
N/A 2035-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | POON CHRISTINE A Director |
2,124 | $0 | 4,310 (Direct) |
View |
| 2024-12-20 Acquisition |
2025-01-06 4:07 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | POON CHRISTINE A Director |
14 | $0 | 4,310 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:06 pm |
N/A 2035-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | Guarini Kathryn Director |
2,124 | $0 | 2,406 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:06 pm |
N/A 2035-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director |
2,124 | $0 | 8,506 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:05 pm |
N/A 2035-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
2,124 | $0 | 14,668 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:04 pm |
N/A 2035-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
2,124 | $0 | 3,506 (Direct) |
View |
| 2024-12-31 Exercise |
2025-01-03 4:02 pm |
N/A 2025-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
3,338 | $0 | 31,936 (Direct) |
View |
| 2024-12-31 Tax Withholding |
2025-01-03 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
1,948 | $708.19 | 31,936 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-03 4:02 pm |
N/A 2035-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
2,124 | $0 | 31,936 (Direct) |
View |
| 2024-12-31 Exercise |
2025-01-03 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
3,338 | $413.33 | 31,936 (Direct) |
View |
| 2024-12-16 Tax Withholding |
2024-12-18 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
969 | $730.81 | 35,892 (Direct) |
View |
| 2024-12-16 Tax Withholding |
2024-12-18 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
304 | $730.81 | 59,283 (Direct) |
View |
| 2024-12-16 Tax Withholding |
2024-12-18 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Pitofsky Jason VP Controller |
298 | $730.81 | 4,854 (Direct) |
View |
| 2024-12-16 Tax Withholding |
2024-12-18 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
1,054 | $730.81 | 53,400 (Direct) |
View |
| 2024-12-16 Tax Withholding |
2024-12-18 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
759 | $730.81 | 14,404 (Direct) |
View |
| 2024-12-16 Tax Withholding |
2024-12-18 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
702 | $730.81 | 39,446 (Direct) |
View |
| 2024-12-16 Tax Withholding |
2024-12-18 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Finance & CFO |
491 | $730.81 | 19,727 (Direct) |
View |
| 2024-04-04 Gift |
2024-12-10 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Pitofsky Jason VP Controller |
179 | $0 | 8,388 (Indirect) |
View |
| 2024-12-06 Option Award |
2024-12-10 4:03 pm |
N/A 2034-12-06 |
REGENERON PHARMACEUTICALS INC. | REGN | Pitofsky Jason VP Controller |
4,143 | $0 | 8,388 (Direct) |
View |
| 2024-12-09 Tax Withholding |
2024-12-10 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Pitofsky Jason VP Controller |
149 | $787 | 8,388 (Direct) |
View |
| 2024-12-06 Option Award |
2024-12-10 4:03 pm |
N/A 2034-12-06 |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Finance & CFO |
12,570 | $0 | 30,197 (Direct) |
View |
| 2024-12-09 Tax Withholding |
2024-12-10 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Finance & CFO |
1,140 | $787 | 30,197 (Direct) |
View |
| 2024-12-09 Tax Withholding |
2024-12-10 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
466 | $787 | 59,587 (Direct) |
View |
| 2024-12-06 Option Award |
2024-12-10 4:03 pm |
N/A 2034-12-06 |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
16,971 | $0 | 50,333 (Direct) |
View |
| 2024-12-09 Tax Withholding |
2024-12-10 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
492 | $787 | 50,333 (Direct) |
View |
| 2024-12-06 Option Award |
2024-12-10 4:03 pm |
N/A 2034-12-06 |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
16,971 | $0 | 67,926 (Direct) |
View |
| 2024-12-09 Tax Withholding |
2024-12-10 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
492 | $787 | 67,926 (Direct) |
View |
| 2024-12-06 Option Award |
2024-12-10 4:03 pm |
N/A 2034-12-06 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
11,313 | $0 | 24,144 (Direct) |
View |
| 2024-12-09 Tax Withholding |
2024-12-10 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
274 | $787 | 24,144 (Direct) |
View |
| 2024-12-06 Option Award |
2024-12-10 4:02 pm |
N/A 2034-12-06 |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
11,313 | $0 | 49,129 (Direct) |
View |
| 2024-12-09 Tax Withholding |
2024-12-10 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
492 | $787 | 49,129 (Direct) |
View |
| 2024-11-08 Gift |
2024-11-12 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
1,185 | $0 | 51,447 (Direct) |
View |
| 2024-11-01 Exercise |
2024-11-05 4:23 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $381.4 | 19,105 (Direct) |
View |
| 2024-11-01 Exercise |
2024-11-05 4:23 pm |
N/A 2028-12-12 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $0 | 19,105 (Direct) |
View |
| 2024-10-01 Exercise |
2024-10-03 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $381.4 | 20,105 (Direct) |
View |
| 2024-10-01 Exercise |
2024-10-03 4:02 pm |
N/A 2028-12-12 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $0 | 20,105 (Direct) |
View |
| 2024-09-04 Gift |
2024-09-05 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
1,200 | $0 | 28,422 (Direct) |
View |
| 2024-09-03 Exercise |
2024-09-05 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $381.4 | 21,105 (Direct) |
View |
| 2024-09-03 Exercise |
2024-09-05 4:01 pm |
N/A 2028-12-12 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $0 | 21,105 (Direct) |
View |
| 2024-08-15 Exercise |
2024-08-19 4:02 pm |
N/A 2029-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
756 | $0 | 2,898 (Direct) |
View |
| 2024-08-15 Exercise |
2024-08-19 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
756 | $371.4 | 2,898 (Direct) |
View |
| 2024-08-15 Exercise |
2024-08-19 4:01 pm |
N/A 2025-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | POON CHRISTINE A Director |
10,838 | $0 | 2,172 (Direct) |
View |
| 2024-08-15 Exercise |
2024-08-19 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | POON CHRISTINE A Director |
10,838 | $413.33 | 2,172 (Direct) |
View |
| 2024-08-13 Exercise |
2024-08-15 4:01 pm |
N/A 2024-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
20,000 | $0 | 52,632 (Direct) |
View |
| 2024-08-13 Exercise |
2024-08-15 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
20,000 | $399.66 | 52,632 (Direct) |
View |
| 2024-08-13 Tax Withholding |
2024-08-15 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
13,637 | $1,141 | 52,632 (Direct) |
View |
| 2024-08-13 Gift |
2024-08-14 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
500 | $0 | 60,053 (Direct) |
View |
| 2024-08-12 Gift |
2024-08-12 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
900 | $0 | 60,553 (Direct) |
View |
| 2024-08-07 Exercise |
2024-08-07 4:40 pm |
N/A 2029-12-11 |
REGENERON PHARMACEUTICALS INC. | REGN | Pitofsky Jason VP Controller |
487 | $0 | 4,214 (Direct) |
View |
| 2024-08-07 Exercise |
2024-08-07 4:40 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Pitofsky Jason VP Controller |
487 | $372.46 | 4,214 (Direct) |
View |
| 2024-08-02 Tax Withholding |
2024-08-06 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
18,441 | $1,093 | 111,650 (Direct) |
View |
| 2024-08-02 Exercise |
2024-08-06 4:03 pm |
N/A 2025-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
23,638 | $0 | 111,650 (Direct) |
View |
| 2024-08-02 Exercise |
2024-08-06 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
23,638 | $555.67 | 111,650 (Direct) |
View |